Skip to content

Azenta AZTA Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Labcorp Holdings logo
Labcorp HoldingsLH
Illumina logo
IlluminaILMN
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
BioLife Solutions logo
BioLife SolutionsBLFS

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-16.3%
Enterprise value$1.03B
P/S1.8×-0.2×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's software and technology licenses, net?
Azenta (AZTA) reported software and technology licenses, net of $8.81M in Q1 2026.
What is the long-term trend for Azenta's software and technology licenses, net?
Over 4 years (2020 to 2025), Azenta's software and technology licenses, net has grown at a -40.8% compound annual growth rate (CAGR), from $49.78M to $6.12M.